Viroblock SA Hires Dr. Jamie Paterson as CEO

05-Feb-2010 - Switzerland

Viroblock SA, a start-up dedicated to developing and commercializing a new generation of anti-viral products, announced that Dr. Jamie Paterson will join Viroblock as Chief Executive Officer (CEO).

Jamie Paterson, a British national, can look back at 20 years of experience in the pharmaceutical industry. Prior to joining Viroblock he was Chief Commercial Officer at Neurim Pharmaceuticals. During his 18 years at Procter & Gamble he held several positions with increasing responsibility including Marketing Manager Italy and Commercial Director Spain. His final position at P&G was European Director of Strategic Planning and New Business Development - Rx & OTC. Jamie holds a PhD in Biochemistry from Imperial College, University of London.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances